Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01250
|
|||||
| Drug Name |
Spermidine
|
|||||
| Synonyms |
124S209; 1pot; 4-04-00-01300 (Beilstein Handbook Reference); =99% (GC); AC1L1AQB; ACMC-20ajn3; AI3-26636; AJ-26792; AKOS006222987; AN-22947; ATHGHQPFGPMSJY-UHFFFAOYSA-N; Aminopropylbutandiamine; BDBM50009353; BPBio1_001276; BRN 1698591; BSPBio_002613; Biomol-NT_000212; C00315; CCG-205124; CHEBI:16610; CHEMBL19612; CS-0013804; CTK3J1693; DB-026892; DB03566; DTXSID4036645; DivK1c_001007; EINECS 204-689-0; FT-0629162; GTPL2390; HY-B1776; IDI1_001007; KBio1_001007; KBio2_000345; KBio2_002913; KBio2_005481; KBio3_001833; KBioGR_001542; KBioSS_000345; LS-45643; Lopac-S-2501; Lopac0_001047; M923; MCULE-8096530192; MFCD00008229; MolPort-001-761-230; N-(3-Aminopropyl)-4-aminobutylamine; N-(4-Aminobutyl)-1,3-diaminopropane; NCGC00015937-01; NCGC00015937-02; NCGC00015937-03; NCGC00015937-04; NCGC00015937-05; NCGC00024903-01; NCGC00024903-02; NCGC00024903-03; NCI60_004294; NINDS_001007; NSC528399; PA(34); RTR-003757; SC-69371; SCHEMBL15618; SDCCGMLS-0066822.P001; SPBio_000947; SR0; ST24048721; ST45025991; Spectrum2_000874; Spectrum3_000977; Spectrum4_001101; Spectrum5_001561; Spectrum_000005; Spermidin; Spermidine 0.1 M solution; Spermidine hydrochloride; Spermidine, > Spermidine, analytical standard; TR-003757; Tocris-0959; U87FK77H25; UNII-U87FK77H25; ZINC1532612; bmse000116; bmse000951; bmse000955
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Plaque psoriasis [ICD11: EA90.0] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C7H19N3
|
|||||
| Canonical SMILES |
C(CCNCCCN)CN
|
|||||
| InChI |
InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2
|
|||||
| InChIKey |
ATHGHQPFGPMSJY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 124-20-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 145.25 | Topological Polar Surface Area | 64.099 | ||
| Heavy Atom Count | 10 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
11111787
, 11113819
, 11336182
, 11361421
, 11362759
, 11365321
, 11367883
, 11371932
, 11374680
, 11376045
, 11408685
, 11462393
, 11484683
, 11488690
, 11490792
, 11492915
, 11493819
, 11537848
, 15146776
, 17436308
, 24439453
, 24771118
, 24845842
, 24888388
, 24888389
, 24899434
, 24899529
, 24899590
, 26706955
, 26710067
, 26713681
, 26737363
, 26751992
, 3134393
, 31647434
, 3609
, 46392889
, 46504199
, 46504202
, 46506086
, 47365289
, 47440358
, 5612033
, 600884
, 7890553
, 8143482
, 8150974
, 825208
, 829689
, 833127
|
|||||
| ChEBI ID |
CHEBI:16610
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| SLC18B1 | Transporter Info | MFS-type transporter SLC18B1 | Substrate | [3] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | SLC18B1 | Transporter Info | Km = 4200 microM | High five cells-SLC18B1 | [3] | |
| References | ||||||
| 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||||
| 2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
| 3 | Identification of a mammalian vesicular polyamine transporter. Sci Rep. 2014 Oct 30;4:6836. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.